Merck KGaA Hostile Takeover Offer For Schering AG Will Open In Early April
This article was originally published in The Pink Sheet Daily
Merck believes it can assemble a 51% stake in Schering by mid-May, despite opposition by the company’s board.
You may also be interested in...
Schering responds that Merck’s €77 per share takeover offer “undervalues” the firm and its future prospects.
Firm notes strong uptake of the product in 2006, as well as more than $400 million in Thalomid sales for the year during earnings call.
Agreements expand the firm’s position in the COPD space, while also entering obesity, diabetes and metabolic syndrome space.